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Figure S1. Line-scan fluorescence measurement of glass device using microscope (background was not subtracted). Intensity measured in arbitrary units (a.u.).
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Figure S2
Quantification results of λ-phage DNA concentration (copies/mL) on SlipChip using dLAMP plotted against concentration measured by Qubit fluorometer (n=2). Error bars represent standard deviation.
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Sequences of primers and HIV viral RNA used in the paper
Primers used for RT-LAMP amplification were selected from a previous publication 1 LTR primers used for RT-PCR amplification were the same as in a previous publication 2 . 
Sequencing results for HIV viral RNA at p24 gene region
Fabrication of SlipChips
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The procedure of fabricating desired glass SlipChips using soda lime glass was based on previous work. 2, 3 The two-step exposing-etching protocol was adapted to create wells of two different depths (5 µm for thermal expansion wells, 55 µm for all the other wells). After etching, the glass plates were thoroughly cleaned with piranha acid and DI water, and dried with nitrogen gas. The glass plates were then oxidized in a plasma cleaner for 10 minutes and immediately transferred into a desiccator for 1 hour of silanization. They were rinsed thoroughly with chloroform, acetone, and ethanol, and dried with nitrogen gas before use.
Plastic polycarbonate SlipChip devices were directly oxidized in a plasma cleaner for 15 minutes after they were received from microfluidic ChipShop GmbH, and then transferred into a desiccator for 90 minutes of silanization. They were soaked in tetradecane for 15 minutes at 65 °C and then rinsed thoroughly with ethanol, then dried with nitrogen gas before use. Plastic SlipChip devices were not reused.
Assembling and loading the SlipChips
The SlipChips were assembled under de-gassed oil (mineral oil: tetradecane 1:4 v/v). Both top and bottom plates were immersed into the oil phase and placed face to face. The two plates were aligned under a stereoscope (Leica, Germany) as shown in Figure 2 and fixed using binder clips.
Two through-holes were drilled in the top plate to serve as fluid inlets. The reagent solution was loaded through the inlet by pipetting.
HIV viral RNA purification from AcroMetrix® HIV-1 Panel Copies/mL
400 µL plasma containing a modified HIV virus (5 million copies/mL, part of AcroMetrix® HIV-1 Panel Copies/mL) was loaded onto the iPrep™ PureLink® Virus cartridge. The cartridge was SI8 placed in the iPrep™ purification instrument and the purification protocol was performed according to the manufacturer's instructions. The elution volume was 50 µL. The purified HIV viral RNA was diluted 10, 10 2 , 10 3 fold in 1 mg/mL BSA solution, aliquoted and stored at -80 °C for further use. HIV viral RNA purified from patient plasma was also aliquoted and stored at -80 °C upon receipt.
Image acquisition and analysis
The bright-field image in Figure 2 The data analysis method was adapted from a previous publication. 4 
